Lv31
202 积分 2021-07-21 加入
Finding a needle in the haystack: ADME and pharmacokinetics/pharmacodynamics characterization and optimization toward orally available bifunctional protein degraders
4小时前
待确认
Nanoenabled Strategies Enhancing PROTACs for Cancer Therapy
6天前
已完结
Metabolism and disposition of the SGLT2 inhibitor bexagliflozin in rats, monkeys and humans
2个月前
已完结
A Review of the Safety and Efficacy of Bexagliflozin for the Management of Type 2 Diabetes
2个月前
已完结
Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review
3个月前
已完结
Development of PROTAC Degrader Drugs for Cancer
4个月前
已完结
Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer
5个月前
已完结
Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC
5个月前
已完结
Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient Treatment of Acute Myeloid Leukemia and Overcoming Resistance of FLT3 Inhibitors
5个月前
已完结
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia
5个月前
已完结
皖公网安备34019202002308
